Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1089

1.

Public Health Risk of Designer Psychotropic Drugs: Should PHASE Be Phased In?

Greenblatt DJ.

Clin Pharmacol Ther. 2019 Aug 22. doi: 10.1002/cpt.1578. [Epub ahead of print] No abstract available.

PMID:
31441050
2.

Effect of first-line antituberculosis therapy on nevirapine pharmacokinetics in children younger than 3 years old.

Enimil A, Antwi S, Yang H, Dompreh A, Alghamdi WA, Gillani FS, Orstin A, Bosomtwe D, Opoku T, Norman J, Wiesner L, Langaee T, Peloquin CA, Court MH, Greenblatt DJ, Kwara A.

Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00839-19. doi: 10.1128/AAC.00839-19. [Epub ahead of print]

PMID:
31332062
3.

Methadone Disposition: Implementing Lessons Learned.

Kharasch ED, Greenblatt DJ.

J Clin Pharmacol. 2019 Aug;59(8):1044-1048. doi: 10.1002/jcph.1427. Epub 2019 May 1. No abstract available.

PMID:
31044453
4.

Zolpidem and Gender: Are Women Really At Risk?

Greenblatt DJ, Harmatz JS, Roth T.

J Clin Psychopharmacol. 2019 May/Jun;39(3):189-199. doi: 10.1097/JCP.0000000000001026.

PMID:
30939589
5.

Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity.

Uchimura T, Nakamura DS, Link EM, Noguchi Y, Ōmura S, Sunazuka T, Greenblatt DJ, Zeng L.

Biochem Pharmacol. 2019 Jul;165:79-90. doi: 10.1016/j.bcp.2019.03.014. Epub 2019 Mar 9.

PMID:
30862504
6.

Prolonged therapy with the anticonvulsant carbamazepine leads to increased plasma clearance of fentanyl.

Nozari A, Akeju O, Mirzakhani H, Eskandar E, Ma Z, Hossain MA, Wang Q, Greenblatt DJ, Martyn JAJ.

J Pharm Pharmacol. 2019 Jun;71(6):982-987. doi: 10.1111/jphp.13079. Epub 2019 Feb 21.

PMID:
30793320
7.

Designer Benzodiazepines: A Review of Published Data and Public Health Significance.

Greenblatt HK, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2019 Apr;8(3):266-269. doi: 10.1002/cpdd.667. Epub 2019 Feb 7. No abstract available.

PMID:
30730611
8.

Ketoconazole and Liver Injury: A Five-Year Update.

Greenblatt DJ, Mikus G.

Clin Pharmacol Drug Dev. 2019 Jan;8(1):6-8. doi: 10.1002/cpdd.652. No abstract available.

PMID:
30599463
9.

Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid.

Matin B, Sherbini AA, Alam N, Harmatz JS, Greenblatt DJ.

J Pharm Pharmacol. 2019 Mar;71(3):371-378. doi: 10.1111/jphp.13037. Epub 2018 Nov 12.

PMID:
30417385
10.

Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old.

Kwara A, Yang H, Antwi S, Enimil A, Gillani FS, Dompreh A, Ortsin A, Opoku T, Bosomtwe D, Sarfo A, Wiesner L, Norman J, Alghamdi WA, Langaee T, Peloquin CA, Court MH, Greenblatt DJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01657-18. doi: 10.1128/AAC.01657-18. Print 2019 Jan.

11.

Is There Always a Right or Wrong?: Comments on the FDA Warnings About Triptans and the Serotonin Syndrome.

Shader RI, Greenblatt DJ.

J Clin Psychopharmacol. 2018 Dec;38(6):545-546. doi: 10.1097/JCP.0000000000000965. No abstract available.

PMID:
30303862
12.

Therapeutic Drug Monitoring of Antidepressants.

Fiaturi N, Greenblatt DJ.

Handb Exp Pharmacol. 2019;250:115-133. doi: 10.1007/164_2018_161.

PMID:
30194543
13.

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach.

Nardi AE, Cosci F, Balon R, Weintraub SJ, Freire RC, Krystal JH, Roth T, Silberman EK, Sonino N, Fava GA, Starcevic V, Dubovsky SL, Salzman C, Rickels K, Greenblatt DJ, Shader RI, Chouinard G; International Task Force on Benzodiazepines.

J Clin Psychopharmacol. 2018 Aug;38(4):283-285. doi: 10.1097/JCP.0000000000000908. No abstract available.

PMID:
29912790
14.

Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient Safety.

Greenblatt DJ, Harmatz JS, Ryan MJ, Chow CR.

J Clin Psychopharmacol. 2018 Aug;38(4):289-295. doi: 10.1097/JCP.0000000000000892.

PMID:
29851709
15.

International Task Force on Benzodiazepines.

Balon R, Chouinard G, Cosci F, Dubovsky SL, Fava GA, Freire RC, Greenblatt DJ, Krystal JH, Nardi AE, Rickels K, Roth T, Salzman C, Shader R, Silberman EK, Sonino N, Starcevic V, Weintraub SJ.

Psychother Psychosom. 2018;87(4):193-194. doi: 10.1159/000489538. Epub 2018 May 22. No abstract available.

16.

Persistence of a Posaconazole-Mediated Drug-Drug Interaction With Ranolazine After Cessation of Posaconazole Administration: Impact of Obesity and Implications for Patient Safety.

Chow CR, Harmatz JS, Ryan MJ, Greenblatt DJ.

J Clin Pharmacol. 2018 Nov;58(11):1436-1442. doi: 10.1002/jcph.1257. Epub 2018 May 11.

PMID:
29749631
17.

Opportunistic Journals in the Clinical Pharmacology Space: A Policy Statement From the Publications and Public Policy Committees of the American College of Clinical Pharmacology.

Greenblatt DJ, Bertino JS Jr.

J Clin Pharmacol. 2018 May;58(5):567-571. doi: 10.1002/jcph.1130. No abstract available.

PMID:
29677401
18.

Opportunistic Journals in the Clinical Pharmacology Space: A Policy Statement From the Publications and Public Policy Committees of the American College of Clinical Pharmacology.

Greenblatt DJ, Bertino JS Jr.

Clin Pharmacol Drug Dev. 2018 May;7(4):353-357. doi: 10.1002/cpdd.466. No abstract available.

PMID:
29677400
19.

Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety.

Greenblatt DJ, Harmatz JS, Chow CR.

J Clin Psychopharmacol. 2018 Jun;38(3):172-179. doi: 10.1097/JCP.0000000000000861.

PMID:
29596146
20.

Gabapentin and Pregabalin for the Treatment of Anxiety Disorders.

Greenblatt HK, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2018 Mar;7(3):228-232. doi: 10.1002/cpdd.446. No abstract available.

PMID:
29579375
21.

Inhibitory effects of sulfonylureas and non-steroidal anti-inflammatory drugs on in vitro metabolism of canagliflozin in human liver microsomes.

Algeelani S, Alkhelb D, Greenblatt DJ.

Biopharm Drug Dispos. 2018 Mar;39(3):135-142. doi: 10.1002/bdd.2120. Epub 2018 Feb 22.

PMID:
29319909
22.

Opioid Prescribing: What Are the Numbers?

Greenblatt DJ.

Clin Pharmacol Drug Dev. 2018 Jan;7(1):6-8. doi: 10.1002/cpdd.430. No abstract available.

PMID:
29276940
23.

Update on Psychotropic Drug Prescribing in the United States: 2014-2015.

Greenblatt DJ, Harmatz JS, Shader RI.

J Clin Psychopharmacol. 2018 Feb;38(1):1-4. doi: 10.1097/JCP.0000000000000831. No abstract available.

PMID:
29215384
24.

Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.

25.

Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection.

Greenblatt DJ, Patel M, Harmatz JS, Nicholson WT, Rubino CM, Chow CR.

J Clin Pharmacol. 2018 Apr;58(4):533-540. doi: 10.1002/jcph.1040. Epub 2017 Nov 30.

PMID:
29194698
26.

Mechanism of in-vitro inhibition of UGT1A1 by paritaprevir.

Alam N, Angeli MG, Greenblatt DJ.

J Pharm Pharmacol. 2017 Dec;69(12):1794-1801. doi: 10.1111/jphp.12821. Epub 2017 Oct 9.

PMID:
28990653
27.

Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat.

Hossain MA, Tran T, Chen T, Mikus G, Greenblatt DJ.

J Pharm Pharmacol. 2017 Dec;69(12):1786-1793. doi: 10.1111/jphp.12820. Epub 2017 Sep 29.

PMID:
28960344
28.

In vitro inhibition of human UGT isoforms by ritonavir and cobicistat.

Algeelani S, Alam N, Hossain MA, Mikus G, Greenblatt DJ.

Xenobiotica. 2018 Aug;48(8):764-769. doi: 10.1080/00498254.2017.1370655. Epub 2017 Sep 11.

PMID:
28891378
29.

Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.

Cao L, Kwara A, Greenblatt DJ.

J Pharm Pharmacol. 2017 Dec;69(12):1762-1772. doi: 10.1111/jphp.12812. Epub 2017 Sep 5.

30.

Recent Recall of a Generic Form of Extended-Release Paliperidone.

Shader RI, Greenblatt DJ.

J Clin Psychopharmacol. 2017 Oct;37(5):493-494. doi: 10.1097/JCP.0000000000000765. No abstract available.

PMID:
28786829
31.

Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.

Court MH, Zhu Z, Masse G, Duan SX, James LP, Harmatz JS, Greenblatt DJ.

J Pharmacol Exp Ther. 2017 Sep;362(3):431-440. doi: 10.1124/jpet.117.242107. Epub 2017 Jun 29.

32.

Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.

Cao L, Greenblatt DJ, Kwara A.

Drug Metab Dispos. 2017 Sep;45(9):1035-1043. doi: 10.1124/dmd.117.076034. Epub 2017 Jun 29.

33.

The Impact Non-Factor.

Greenblatt DJ, Shader RI.

J Clin Psychopharmacol. 2017 Aug;37(4):389-390. doi: 10.1097/JCP.0000000000000743. No abstract available.

PMID:
28609306
34.

The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor.

Bertino JS Jr, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2017 May;6(3):218-219. doi: 10.1002/cpdd.359. No abstract available.

PMID:
28475820
35.

The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor.

Bertino JS Jr, Greenblatt DJ.

J Clin Pharmacol. 2017 May;57(5):545-546. doi: 10.1002/jcph.909. No abstract available.

PMID:
28409839
36.

Mechanisms and Consequences of Drug-Drug Interactions.

Greenblatt DJ.

Clin Pharmacol Drug Dev. 2017 Mar;6(2):118-124. doi: 10.1002/cpdd.339.

PMID:
28263467
37.

Pharmacokinetics cannot explain the increased effective dose requirement for morphine and midazolam in rats during their extended administration alone or in combination.

Schaller SJ, Alam SM, Mao J, Zhao Y, Blobner M, Greenblatt DJ, Martyn JA.

J Pharm Pharmacol. 2017 Jan;69(1):82-88. doi: 10.1111/jphp.12663. Epub 2016 Nov 28.

PMID:
27891611
38.

Clinical Pharmacology in Drug Development: Five Years in the Books.

Greenblatt DJ.

Clin Pharmacol Drug Dev. 2016 Nov;5(6):432-434. doi: 10.1002/cpdd.322. No abstract available.

PMID:
27870478
39.

Antidepressant-Associated Hyponatremia in the Elderly.

Greenblatt HK, Greenblatt DJ.

J Clin Psychopharmacol. 2016 Dec;36(6):545-549. Review. No abstract available.

PMID:
27755157
40.

Elements of a Good Scientific Paper.

Shader RI, Greenblatt DJ.

J Clin Psychopharmacol. 2016 Dec;36(6):539-541. No abstract available.

PMID:
27753727
41.

Stereo-Psychopharmacology: The Case of Citalopram and Escitalopram.

Ng I, Greenblatt HK, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2016 Sep;5(5):331-5. doi: 10.1002/cpdd.293. No abstract available.

PMID:
27452501
42.

Body Size Changes Among National Collegiate Athletic Association New England Division III Football Players, 1956-2014: Comparison With Age-Matched Population Controls.

Elliott KR, Harmatz JS, Zhao Y, Greenblatt DJ.

J Athl Train. 2016 May;51(5):373-81. doi: 10.4085/1062-6050-51.5.14. Epub 2016 May 9.

43.

Clinical pharmacology in drug development - an update.

Greenblatt DJ.

Clin Pharmacol Drug Dev. 2015 Jul;4(4):243-4. doi: 10.1002/cpdd.211. No abstract available.

PMID:
27136903
44.

Meldonium (Mildronate): A Performance-Enhancing Drug?

Greenblatt HK, Greenblatt DJ.

Clin Pharmacol Drug Dev. 2016 May;5(3):167-9. doi: 10.1002/cpdd.264. Epub 2016 Apr 29. No abstract available.

PMID:
27128409
45.

A soft benzodiazepine.

Greenblatt DJ.

Clin Pharmacol Drug Dev. 2015 Mar;4(2):81-2. doi: 10.1002/cpdd.186. No abstract available.

PMID:
27128211
46.

Pharmacokinetics and Pharmacodynamics for Medical Students: A Proposed Course Outline.

Greenblatt DJ, Abourjaily PN.

J Clin Pharmacol. 2016 Oct;56(10):1180-95. doi: 10.1002/jcph.732. Epub 2016 May 9. No abstract available.

PMID:
26987681
47.

Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.

Greenblatt HK, Greenblatt DJ.

J Clin Pharmacol. 2016 Sep;56(9):1048-57. doi: 10.1002/jcph.731. Epub 2016 Apr 29. Review.

PMID:
26953213
48.

In Memoriam: David A. Flockhart, 1952-2015.

Greenblatt DJ, Abernethy DR.

J Clin Pharmacol. 2016 Apr;56(4):509-10. doi: 10.1002/jcph.726. Epub 2016 Feb 26. No abstract available.

PMID:
26919538
49.

A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.

Weiss MD, Macklin EA, Simmons Z, Knox AS, Greenblatt DJ, Atassi N, Graves M, Parziale N, Salameh JS, Quinn C, Brown RH Jr, Distad JB, Trivedi J, Shefner JM, Barohn RJ, Pestronk A, Swenson A, Cudkowicz ME; Mexiletine ALS Study Group.

Neurology. 2016 Apr 19;86(16):1474-81. doi: 10.1212/WNL.0000000000002507. Epub 2016 Feb 24.

50.

Ketoconazole-Associated Liver Injury in Drug-Drug Interaction Studies in Healthy Volunteers.

Banankhah PS, Garnick KA, Greenblatt DJ.

J Clin Pharmacol. 2016 Oct;56(10):1196-202. doi: 10.1002/jcph.711. Epub 2016 Feb 29. Review.

PMID:
26829173

Supplemental Content

Loading ...
Support Center